HK1133874A1 - Novel heterocyclic compound or salt thereof and intermediate thereof - Google Patents

Novel heterocyclic compound or salt thereof and intermediate thereof

Info

Publication number
HK1133874A1
HK1133874A1 HK09110473.6A HK09110473A HK1133874A1 HK 1133874 A1 HK1133874 A1 HK 1133874A1 HK 09110473 A HK09110473 A HK 09110473A HK 1133874 A1 HK1133874 A1 HK 1133874A1
Authority
HK
Hong Kong
Prior art keywords
salt
heterocyclic compound
novel heterocyclic
novel
compound
Prior art date
Application number
HK09110473.6A
Other languages
English (en)
Inventor
Taro Kiyoto
Junichi Ando
Tadashi Tanaka
Yasuhiro Tsutsui
Mai Yokotani
Toshiya Noguchi
Fumihito Ushiyama
Hiroki Urabe
Hiromasa Horikiri
Original Assignee
Toyama Chemical Co Ltd
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd, Taisho Pharmaceutical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of HK1133874A1 publication Critical patent/HK1133874A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK09110473.6A 2006-05-26 2009-11-10 Novel heterocyclic compound or salt thereof and intermediate thereof HK1133874A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006146588 2006-05-26
PCT/JP2007/060606 WO2007138974A1 (ja) 2006-05-26 2007-05-24 新規な複素環化合物またはその塩ならびにその中間体

Publications (1)

Publication Number Publication Date
HK1133874A1 true HK1133874A1 (en) 2010-04-09

Family

ID=38778494

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09110473.6A HK1133874A1 (en) 2006-05-26 2009-11-10 Novel heterocyclic compound or salt thereof and intermediate thereof

Country Status (18)

Country Link
US (2) US8211908B2 (ru)
EP (1) EP2022793B1 (ru)
JP (1) JP5171618B2 (ru)
KR (1) KR101409261B1 (ru)
CN (1) CN101454319B (ru)
AU (1) AU2007268749B2 (ru)
BR (1) BRPI0712163A2 (ru)
CA (1) CA2652501C (ru)
ES (1) ES2476423T3 (ru)
HK (1) HK1133874A1 (ru)
IL (1) IL195346A (ru)
MX (1) MX2008014908A (ru)
NO (1) NO20084701L (ru)
NZ (1) NZ573032A (ru)
RU (1) RU2434868C2 (ru)
SG (1) SG164384A1 (ru)
WO (1) WO2007138974A1 (ru)
ZA (1) ZA200809782B (ru)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
JP5398984B2 (ja) 2005-06-24 2014-01-29 富山化学工業株式会社 新規な含窒素複素環化合物およびその塩
AU2006335042A1 (en) * 2005-10-21 2007-07-19 Glaxo Group Limited Compounds
KR101409261B1 (ko) 2006-05-26 2014-06-18 다이쇼 세이야꾸 가부시끼가이샤 신규의 복소환 화합물 또는 그 염 및 그 중간체
JP5315239B2 (ja) * 2006-07-20 2013-10-16 グラクソ グループ リミテッド Ｎ−エチルキノロンおよびｎ−エチルアザキノロンの誘導体およびアナログ
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
TW200831517A (en) * 2006-12-15 2008-08-01 Astrazeneca Ab Chemical compounds
WO2008071962A1 (en) * 2006-12-15 2008-06-19 Astrazeneca Ab Pteridines and pyrimidinopyridines as antibacterial agents
WO2008071964A1 (en) * 2006-12-15 2008-06-19 Astrazeneca Ab Naphthyridine bactericides
US20100144717A1 (en) * 2006-12-15 2010-06-10 Janelle Comita-Prevoir 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents
US8354426B2 (en) * 2007-11-26 2013-01-15 Toyama Chemical Co., Ltd. Naphthyridine derivative monohydrate and method for producing the same
JP5620636B2 (ja) * 2007-11-26 2014-11-05 富山化学工業株式会社 新規な複素環化合物またはその塩を含有する抗菌剤
EP2080761A1 (en) * 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
BRPI0908208A2 (pt) 2008-02-22 2015-08-25 Actelion Pharmaceuticals Ltd Composto derivado de oxazolidinona, medicamento, composição farmacêutica que o contém e uso desse composto.
US8349829B2 (en) 2008-06-03 2013-01-08 Actelion Pharmaceuticals Ltd. [4-(1-amino-ethyl)-cyclohexyl]-methyl-amine and [6-(1-amino-ethyl)-tetrahydro-pyran-3-yl]-methyl-amine derivatives as antibacterials
EP2341052A4 (en) * 2008-09-05 2011-10-12 Shionogi & Co RING-CONDENSED MORPHOLINE DERIVATIVITY WITH PI3K-INHIBITING EFFECT
CN102164919B (zh) * 2008-10-10 2014-04-09 埃科特莱茵药品有限公司 噁唑烷基抗生素
TW201022279A (en) * 2008-11-14 2010-06-16 Astrazeneca Ab Chemical compounds
NZ591914A (en) 2008-11-17 2013-04-26 Hoffmann La Roche Naphthylacetic acids
JP5653935B2 (ja) * 2009-01-15 2015-01-14 グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ 抗菌薬として有用なナフチリジン―２（１ｈ）−オン化合物
CN102341133A (zh) * 2009-02-02 2012-02-01 麦德托尼克公司 植入式医疗器械的抗菌配件
AR076222A1 (es) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
US20100278895A1 (en) * 2009-04-30 2010-11-04 Medtronic, Inc. Antioxidants and antimicrobial accessories including antioxidants
TW201209056A (en) * 2010-05-25 2012-03-01 Taisho Pharmaceutical Co Ltd Novel heterocyclic compound or salt thereof
US8911427B2 (en) 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system
EP2674430A4 (en) 2011-02-07 2014-07-02 Daiichi Sankyo Co Ltd AMINO-GROUP-PYRROLIDINONE DERIVATIVES
US8470884B2 (en) 2011-11-09 2013-06-25 Hoffmann-La Roche Inc. Alkenyl naphthylacetic acids
JP2014533747A (ja) 2011-11-30 2014-12-15 アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ ３，７−二置換オクタヒドロ−２Ｈ−ピリド［４，３−ｅ］［１，３］オキサジン−２−オン抗生物質
EP2968331B1 (en) * 2013-03-14 2020-07-01 Icahn School of Medicine at Mount Sinai Pyrimidine compounds as kinase inhibitors
TW201722965A (zh) 2015-08-16 2017-07-01 葛蘭素史密斯克藍智慧財產發展有限公司 用於抗菌應用之化合物
JP2021505671A (ja) 2017-12-08 2021-02-18 ザ ロックフェラー ユニバーシティＴｈｅ Ｒｏｃｋｅｆｅｌｌｅｒ Ｕｎｉｖｅｒｓｉｔｙ 中毒症、掻痒症、疼痛および炎症治療用ピラノ［３，４−ｂ］ピラジンカッパオピオイド受容体リガンド
CN111757879A (zh) * 2018-01-29 2020-10-09 卡地拉健康护理有限公司 用作抗菌剂的杂环化合物
CN109678793B (zh) * 2019-01-12 2020-08-04 上海卡洛化学有限公司 一种5-氟-3-氨基吡啶的制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4103257A (en) 1976-05-25 1978-07-25 The United States Of America As Represented By The United States Department Of Energy Azaquinolone dye lasers
US5801183A (en) * 1995-01-27 1998-09-01 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Aza and aza (N-oxy) analogs of glycine/NMDA receptor antagonists
WO1999007682A1 (fr) * 1997-08-08 1999-02-18 Toyama Chemical Co., Ltd. Derives d'acide quinolonecarboxylique ou sels de ces derives
US6603005B2 (en) 2000-11-15 2003-08-05 Aventis Pharma S.A. Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
GB0031088D0 (en) 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
US6696565B2 (en) * 2001-01-17 2004-02-24 Purdue Research Foundation Method and associated pyrimido[4,5-d]pyrimidine-2,5-diones and pyrido[4,3-d]pyrimidin-2-ones for forming nanotubes
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112836D0 (en) * 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
AR040335A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de ciclohexano o ciclohexeno, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento y compuestos intermediarios de utilidad para preparar dicho compuesto
KR20050087832A (ko) * 2002-12-13 2005-08-31 스미스클라인 비참 코포레이션 Ｃｃｒ5 길항제로서 피페리딘 유도체
KR20070002006A (ko) * 2004-02-11 2007-01-04 스미스클라인 비참 코포레이션 Ｈｉｖ 인테그라제 억제제
JP2008505920A (ja) * 2004-07-08 2008-02-28 グラクソ　グループ　リミテッド 抗菌剤
US20070270417A1 (en) * 2004-07-22 2007-11-22 Glaxo Group Limited Antibacterial Agents
JP2008508359A (ja) * 2004-08-02 2008-03-21 グラクソ グループ リミテッド 抗菌剤
JP5314244B2 (ja) * 2004-10-27 2013-10-16 富山化学工業株式会社 新規な含窒素複素環化合物およびその塩
AU2006250987A1 (en) 2005-05-24 2006-11-30 Astrazeneca Ab Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
JP5398984B2 (ja) 2005-06-24 2014-01-29 富山化学工業株式会社 新規な含窒素複素環化合物およびその塩
KR101409261B1 (ko) 2006-05-26 2014-06-18 다이쇼 세이야꾸 가부시끼가이샤 신규의 복소환 화합물 또는 그 염 및 그 중간체
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
WO2008071962A1 (en) 2006-12-15 2008-06-19 Astrazeneca Ab Pteridines and pyrimidinopyridines as antibacterial agents
WO2008071964A1 (en) 2006-12-15 2008-06-19 Astrazeneca Ab Naphthyridine bactericides
WO2009001126A1 (en) 2007-06-27 2008-12-31 Astrazeneca Ab Substituted piperidine derivatives and their use as antibaterial agents
US8354426B2 (en) 2007-11-26 2013-01-15 Toyama Chemical Co., Ltd. Naphthyridine derivative monohydrate and method for producing the same

Also Published As

Publication number Publication date
RU2008151754A (ru) 2010-07-10
EP2022793B1 (en) 2014-06-04
ES2476423T3 (es) 2014-07-14
BRPI0712163A2 (pt) 2012-03-13
AU2007268749B2 (en) 2012-07-26
EP2022793A1 (en) 2009-02-11
KR101409261B1 (ko) 2014-06-18
CN101454319A (zh) 2009-06-10
AU2007268749A1 (en) 2007-12-06
WO2007138974A1 (ja) 2007-12-06
SG164384A1 (en) 2010-09-29
JP5171618B2 (ja) 2013-03-27
NZ573032A (en) 2010-12-24
US8211908B2 (en) 2012-07-03
MX2008014908A (es) 2009-05-13
CA2652501A1 (en) 2007-12-06
US20090198063A1 (en) 2009-08-06
RU2434868C2 (ru) 2011-11-27
US8367831B2 (en) 2013-02-05
IL195346A (en) 2013-02-28
ZA200809782B (en) 2010-02-24
KR20090018976A (ko) 2009-02-24
JPWO2007138974A1 (ja) 2009-10-08
US20120226035A1 (en) 2012-09-06
NO20084701L (no) 2009-02-06
CN101454319B (zh) 2012-06-27
CA2652501C (en) 2014-07-08
IL195346A0 (en) 2009-08-03
EP2022793A4 (en) 2010-09-08

Similar Documents

Publication Publication Date Title
HK1133874A1 (en) Novel heterocyclic compound or salt thereof and intermediate thereof
HUS000510I2 (hu) Oxatiapiprolin vagy N-oxidja vagy sója
IL244442B (en) Compounds of converted acylanilides and their use
EP1900732A4 (en) NOVEL HETEROCYCLIC NITROGENIC COMPOUND AND SALT THEREOF
PL1919907T3 (pl) Związek heterocykliczny
ZA200709051B (en) Heterocyclic compound
EP2065369A4 (en) UREA CONNECTION OR SALT THEREOF
EP2184285A4 (en) Heterocyclic compound and its use
ZA201308294B (en) Heterocyclic compounds and their uses
EP2152079A4 (en) HETEROCYCLIC COMPOUNDS AND USES THEREOF
EP2151440A4 (en) Heterocyclic compound and its use
IL205071A0 (en) Azolecarboxamide compound or salt thereof
EP2181987A4 (en) HETEROCYCLIC COMPOUND AND USE THEREOF
EP2018863A4 (en) FUSED HETEROCYCLIC COMPOUND AND USE
EP2361915A4 (en) NEW HETEROCYCLIC CONNECTION AND APPLICATION THEREOF
HK1123038A1 (en) Heterocyclic compounds
IL193422A0 (en) Amide derivative or salt thereof
IL195158A0 (en) Novel heterocyclic compounds
EP2202223A4 (en) HETEROCYCLIC COMPOUND
EP2210876A4 (en) HETEROCYCLIC CONNECTION
ZA200903401B (en) The uses of the carboxy-amido-triazole compounds and salts thereof
GB0622472D0 (en) Novel heterocyclic derivatives
EP2039695A4 (en) BICYCLIC HETEROCYLIC COMPOUND AND ITS USE
ZA200800142B (en) Heterocyclic compound
ZA200803017B (en) Heterocyclic compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160524